How Often Should You Receive MRD Testing While In Remission?

Name: How Often Should You Receive MRD Testing While In Remission?
Start: 2022-04-12T13:00:00-04:00
End: 2022-04-12T14:00:00-04:00

How Often Should You Receive MRD Testing While In Remission?

Webinar

Apr 12, 2022 / 01:00PM - 02:00PM EDT

Event Description

While remission (or state of complete response) can be an exciting time for myeloma patients, there might be a level of stress surrounding the monitoring of the disease for the inevitable relapse. And while MRD testing can help provide insight on the disease's activity within the body, excessive MRD testing might become costly or negatively affect your quality of life. Here to help share insight on this complicated topic is multiple myeloma specialist Dr. Joshua Richter from Mount Sinai Hospital in NYC. Be prepared to learn with us and come with questions!

Schedule & Agenda

01:00 PM

Introduction

Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Joshua Richter.

01:00 PM

Introduction

Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Joshua Richter.

01:05 PM

Presentation

Joshua Richter, MD.

Dr. Joshua Richter shares his insight on how often MRD testing should be done.

01:05 PM

Presentation

Joshua Richter, MD.

Dr. Joshua Richter shares his insight on how often MRD testing should be done.

01:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

01:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio

Joshua Richter, MD

Joshua Richter, MD, is Associate Professor of Medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology. He is the director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai. Dr. Richter treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, plasma cell leukemia, and Waldenstrom’s Macroglobulinemia. Dr. Richter has extensive experience with clinical trials focused on novel therapies, including antibody therapy and immunotherapy for a precision medicine approach. He has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. He has been published in journals such as the New England Journal of Medicine, Blood, and the Journal of Clinical Oncology.

Read Bio

Join the Conversation

This event is part of the Lab Values and Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.